Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 34438-34439 [2015-14749]
Download as PDF
<![CDATA[
asabaliauskas on DSK5VPTVN1PROD with NOTICES
34438
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
equipment, etc.) of increasing end-user
compliance with proper selection, care,
maintenance, and use of PPT; (10)
provides systematic collection, analysis,
and interpretation of PPT use practices,
including investigation of barriers to
effective PPT use; (11) produces and
disseminates technical information,
research findings, training materials,
and recommendations for PPT to
improve protection of workers; (12)
evaluates and disseminates PPT
performance trends published through
the post market surveillance activities;
and (13) identifies and implements an
effective communication and outreach
program for stakeholders within the
NIOSH sectors to inform end users of
proper selection, care, maintenance, and
use of PPT.
Conformity Verification and
Standards Development Branch (CCLG).
(1) Administers the Department of
Health and Human Services Title 42
Code of Federal Regulations (CFR), Part
84-Respiratory Protective Devices
conformity assessment functions (i.e.
inspection, testing, certification,
documentation control, quality
assurance, and surveillance) including:
(a) Processing respirator approval
applications by verifying conformance
with Federal regulations and national
consensus standards such as
performance, quality, reliability, and
documentation requirements to
determine the effectiveness of
respirators used during entry into or
escape from hazardous atmospheres, (b)
issuing or revoking NIOSH certificates
of approval, (c) evaluating and
maintaining official records on NIOSHcertified respirators including the
establishment of NPPTL and national
databases, (d) recommending NIOSH
policy relating to RPD conformity
verification criteria for traditional and
innovative respirator technologies and
applications, and, (e) investigating and
processing Freedom-of-Information-Act
requests; (2) establishes and administers
an internal audit program to evaluate
the conformity assessment functions of
NPPTL; (3) maintains official files of
policies, standards, standard operating
and test procedures used as the basis for
granting a NIOSH certificate of
approval; (4) provides national
recommendations for effective
conformity assessment programs
associated with non-respiratory PPT; (5)
assesses research findings and translates
them into effective conformity
assessment recommendations for
NIOSH policy, standards, regulations,
and surveillance practices, for new
protective technologies or special
applications of existing technologies; (6)
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
leads NIOSH participation in the
development and promulgation of
national and international consensus
standards, conformity assessment
program criteria and guidance,
establishment of Federal regulations
where necessary, and assesses of
economic impact of Federal regulations;
(7) prepares criteria for proper selection,
recommends national guidance for
effective use (e.g. cautions, limitations,
and restrictions of use) and
maintenance, and provides technical
support; (8) plans and conducts public
meetings to solicit or provide
information concerning technology and
conformity assessment practices; and (9)
prepares and disseminates national
reports related to conformity assessment
of PPT.
Evaluation and Testing Branch
(CCLH). (1) Conducts evaluations and
tests in accordance with prescribed
standard test procedures of RPD in
support of NIOSH conformity
assessment functions that lead to a
NIOSH certificate of approval or its
revocation; (2) conducts quality
management system in-plant
manufacturing-site evaluations
including post market surveillance, and
documents finding and
recommendations in proper reports; (3)
conducts evaluation and testing of PPT
for various purposes, and prepares
reports for dissemination to the public;
(4) provides testing support to the
NPPTL research and standards
development initiatives; (5) develops
evaluation methodologies, and unique
test procedures to address new
protective technologies or special
applications of existing technologies; (6)
conducts post market evaluations of
NIOSH-certified RPD including the
long-term field evaluation program, and
prepares technical information and
reports to improve standards for
certification, selection, care, and use; (7)
administers and conducts surveillance
of field deployed PPT to evaluate
conformance to applicable regulation,
consensus standards, and NIOSH
policy; (8) conducts investigations of
PPT associated with complaints of
nonconformance and/or concerns
related to adverse health and safety
including evaluations and analysis
associated with NIOSH-certified
respirators (e.g. certified product
investigation process), and evaluating
respirators and protective clothing
submitted in conjunction with the
NIOSH Fire Fighter Fatality
Investigation and Prevention Program
investigations conducted by the
Division of Safety Research ; and (9)
maintains and improves laboratory
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
capabilities to perform evaluation and
testing of PPT including innovative
technologies, implements a laboratory
quality program (e.g., ISO 17025) to
ensure quality and continuous
improvement of PPT evaluations and
tests, administers and maintains a chain
of custody program to secure
technologies or products obtained for
evaluation and testing, and conducts an
internal audit function to assure
evaluation and testing are carried out in
accordance policy and standard
procedures.
James Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2015–14686 Filed 6–15–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee:
Time and Date:
1:30 p.m.–2:30 p.m. (EDT), July 17, 2015
Place: This meeting will be held by
teleconference. To participate in the
teleconference, please dial (877) 930–8819
and enter code 1579739.
Status: Open to the public, limited only by
the availability of telephone ports. The
public is welcome to participate during the
public comment period, tentatively
scheduled from 2:20 p.m. until 2:25 p.m.
Purpose: The Advisory Committee to the
Director, CDC, shall advise the Secretary,
HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill
its mission of protecting health through
health promotion, prevention, and
preparedness. The committee recommends
ways to prioritize CDC’s activities, improve
results, and address health disparities. It also
provides guidance to help CDC work more
effectively with its various private and public
sector constituents to make health protection
a practical reality.
Matters for Discussion: The Advisory
Committee to the Director will receive an
update from the External Laboratory Safety
Workgroup.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Carmen Villar, MSW, Designated Federal
Officer, ACD, CDC, 1600 Clifton Road NE.,
M/S D–14, Atlanta, Georgia 30333;
E:\FR\FM\16JNN1.SGM
16JNN1
34439
Federal Register / Vol. 80, No. 115 / Tuesday, June 16, 2015 / Notices
Telephone (404) 639–7158; Email:
GHickman@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Catalog of Federal Domestic Assistance
(CFDA) Number: 93.432.
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Note: On July 22, 2014, President Obama
signed the Workforce Innovation
Opportunity Act (WIOA). WIOA was
effective immediately. One provision of
WIOA transferred the Centers for
Independent Living (CIL) program from the
Department of Education to the
Administration for Community Living (ACL)
in the Department of Health and Human
Services. In addition, the CIL program will be
placed in Independent Living Administration
(ILA) within ACL. For FY 2015, all CIL
program notices will be published as ACL
notices, and ACL will make all CIL awards.
ILA will post previously-approved
application kits to grants.gov, and CIL
applications submitted to grants.gov.
[FR Doc. 2015–14749 Filed 6–15–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Applications for New Awards;
Independent Living Administration
Administration for Community
Living, Department of Health and
Human Services.
AGENCY:
ACTION:
Notice.
Overview Information:
Independent Living Administration—
Centers for Independent Living.
Notice inviting applications for new
awards for fiscal year (FY) 2015.
Note: This notice invites applications for
separate competitions. For funding and other
key information for this competition, see the
chart in the Award Information section of
this notice.
DATES:
Applications Available: June 16,
2015.
Date of Pre-Application Meeting: July
7, 2015.
Deadline for Notice of Intent to
Apply: July 21, 2015.
Deadline for Transmittal of
Applications: August 17, 2015.
Full Text of Announcement
I. Funding Opportunity Description
Purpose of Program: The purpose of
the Center for Independent Living
program provides support for planning,
conducting, administering, and
evaluating centers for independent
living (centers) that comply with the
standards and assurances in section 725
of part C of title VII of the Rehabilitation
Act of 1973, as amended by the
Workforce Innovation and Opportunity
Act (WIOA, Pub. L. 113–128, consistent
with the design included in the State
plan for establishing a statewide
network of centers.
Program Authority: 29 U.S.C. 796f–1.
Applicable Regulations: (a) The
Department of Health and Human
Services General Administrative
Regulations in 45 CFR part 75 (b) Audit
Requirements for Federal Awards in 45
CFR part 75 Subpart F; (c) 45 CFR part
75 Non-procurement Debarment and
Suspension; (d) 45 CFR part 75
Requirement for Drug-Free Workplace
(Financial Assistance); The regulations
for this program in 45 CFR part 350.
Note: The regulations in 34 CFR part 79
apply to all applicants except federally
recognized Indian tribes.
II. Award Information
Type of Award: Discretionary grant.
Estimated Available Funds: $249,142.
Estimated Number of Awards: 2.
Estimated
available funds
States and outlying areas
American Samoa .....................................................................................................................................................
Guam .......................................................................................................................................................................
Note: The Department is not bound by any
estimates in this notice.
Project Period: Up to 60 months.
asabaliauskas on DSK5VPTVN1PROD with NOTICES
III. Eligibility Information
1. Eligible Applicants: To be eligible
for funding, an applicant must—
(a) Be a consumer-controlled,
community-based, cross-disability,
nonresidential, private nonprofit
agency;
(b) Have the power and authority to—
(1) Carry out the purpose of part C of
title VII of the Act and perform the
functions listed in section 725(b) and (c)
of the Act and subparts F and G of 34
CFR part 366 within a community
located within a State or in a bordering
State; and
(2) Receive and administer—
(i) Funds under 34 CFR part 366;
(ii) Funds and contributions from
private or public sources that may be
used in support of a center; and
VerDate Sep<11>2014
17:18 Jun 15, 2015
Jkt 235001
(iii) Funds from other public and
private programs;
(c) Be able to plan, conduct,
administer, and evaluate a center
consistent with the standards and
assurances in section 725(b) and (c) of
the Act and subparts F and G of 34 CFR
part 366;
(d) Either—
(1) Not currently be receiving funds
under part C of chapter 1 of title VII of
the Act; or
(2) Propose the expansion of an
existing center through the
establishment of a separate and
complete center (except that the
governing board of the existing center
may serve as the governing board of the
new center) at a different geographical
location;
(e) Propose to serve one or more of the
geographic areas that are identified as
unserved or underserved by the States
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
Estimated
number of
awards
$154,046
95,096
1
1
and Outlying Areas listed under
Estimated Number of Awards; and
(f) Submit appropriate documentation
demonstrating that the establishment of
a new center is consistent with the
design for establishing a statewide
network of centers in the State plan of
the State or Outlying Area whose
geographic area or areas the applicant
proposes to serve.
2. Cost Sharing or Matching: This
competition does not require cost
sharing or matching.
IV. Application and Submission
Information
1. Address to Request Application
Package: You can obtain an application
package via grants.gov, or by contacting
Veronica Hogan: U.S. Department of
Health and Human Services, 400
Maryland Avenue SW., Room 5044,
PCP, Washington, DC 20202–2800.
E:\FR\FM\16JNN1.SGM
16JNN1
]]>Agencies
[Federal Register Volume 80, Number 115 (Tuesday, June 16, 2015)]
[Notices]
[Pages 34438-34439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-14749]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee to the Director (ACD), Centers for Disease
Control and Prevention (CDC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee:
Time and Date:
1:30 p.m.-2:30 p.m. (EDT), July 17, 2015
Place: This meeting will be held by teleconference. To
participate in the teleconference, please dial (877) 930-8819 and
enter code 1579739.
Status: Open to the public, limited only by the availability of
telephone ports. The public is welcome to participate during the
public comment period, tentatively scheduled from 2:20 p.m. until
2:25 p.m.
Purpose: The Advisory Committee to the Director, CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and
broad strategies that will enable CDC to fulfill its mission of
protecting health through health promotion, prevention, and
preparedness. The committee recommends ways to prioritize CDC's
activities, improve results, and address health disparities. It also
provides guidance to help CDC work more effectively with its various
private and public sector constituents to make health protection a
practical reality.
Matters for Discussion: The Advisory Committee to the Director
will receive an update from the External Laboratory Safety
Workgroup.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Carmen Villar, MSW,
Designated Federal Officer, ACD, CDC, 1600 Clifton Road NE., M/S D-
14, Atlanta, Georgia 30333;
[[Page 34439]]
Telephone (404) 639-7158; Email: GHickman@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-14749 Filed 6-15-15; 8:45 am]
BILLING CODE 4163-18-P
